Arrowhead Pharmaceuticals Inc (ARWR)

Oct 14, 2025

Is Arrowhead Pharmaceuticals Inc. stock attractive for growth ETFs2025 Price Action Summary & Fast Entry Momentum Alerts - newser.com

Oct 14, 2025

Oct 14, 2025

Applying Wyckoff theory to Arrowhead Pharmaceuticals Inc. stockQuarterly Portfolio Report & Target Return Focused Picks - newser.com

Oct 14, 2025

Oct 14, 2025

What Fibonacci levels say about Arrowhead Pharmaceuticals Inc. reboundJuly 2025 Action & Community Consensus Picks - newser.com

Oct 14, 2025

Oct 14, 2025

What to expect from Arrowhead Pharmaceuticals Inc. in the next 30 daysPortfolio Value Report & Intraday High Probability Setup Alerts - newser.com

Oct 14, 2025

Oct 14, 2025

How buybacks impact Arrowhead Pharmaceuticals Inc. stock valueTrade Analysis Summary & Verified Stock Trade Ideas - newser.com

Oct 14, 2025

Oct 14, 2025

Advanced analytics toolkit walkthrough for Arrowhead Pharmaceuticals Inc.Quarterly Market Review & Long-Term Growth Portfolio Plans - newser.com

Oct 14, 2025

Oct 13, 2025

Arrowhead CFO Ken Myszkowski to retire, Daniel Apel to succeed - MSN

Oct 13, 2025

Oct 13, 2025

Sector ETF performance correlation with Arrowhead Pharmaceuticals Inc.2025 Risk Factors & Low Risk High Reward Ideas - newser.com

Oct 13, 2025

Oct 13, 2025

Is Arrowhead Pharmaceuticals Inc. showing signs of accumulationOil Prices & Verified Swing Trading Watchlist - newser.com

Oct 13, 2025

Oct 13, 2025

Arrowhead Pharmaceuticals, Inc. (NASDAQ:ARWR) Given Consensus Recommendation of "Moderate Buy" by Brokerages - MarketBeat

Oct 13, 2025

Oct 13, 2025

Is Arrowhead Pharmaceuticals Inc a good long term investmentSector Performance Review & Free Double Digit Growth Tips - earlytimes.in

Oct 13, 2025

Oct 12, 2025

Arrowhead Pharmaceuticals Inc HDP1 Stock Analysis and ForecastMACD Histogram Signals & Budget Friendly Capital Growth - earlytimes.in

Oct 12, 2025

Oct 12, 2025

Short interest data insights for Arrowhead Pharmaceuticals Inc.July 2025 Snapshot & Free Real-Time Market Sentiment Alerts - newser.com

Oct 12, 2025

Oct 12, 2025

Arrowhead Pharmaceuticals Inc. stock chart pattern explainedEarnings Recap Summary & Community Supported Trade Ideas - newser.com

Oct 12, 2025

Oct 11, 2025

Pinion Investment Advisors LLC Has $1.19 Million Stock Position in Arrowhead Pharmaceuticals, Inc. $ARWR - MarketBeat

Oct 11, 2025

Oct 10, 2025

Arrowhead Pharmaceuticals, Inc. (ARWR) Secures $100M Milestone from Sarepta in RNAi Breakthrough Deal - MSN

Oct 10, 2025

Oct 10, 2025

Will Arrowhead Pharmaceuticals Inc. see short term momentum2025 Price Targets & Daily Market Momentum Tracking - newser.com

Oct 10, 2025

Oct 10, 2025

Has Arrowhead Pharmaceuticals Inc. found a price floorJuly 2025 Fed Impact & Low Drawdown Investment Strategies - newser.com

Oct 10, 2025

Oct 10, 2025

Can Arrowhead Pharmaceuticals Inc. stock deliver surprise earnings beatJuly 2025 EndofMonth & Real-Time Sentiment Analysis - newser.com

Oct 10, 2025

Oct 09, 2025

Weiss Ratings Reaffirms Sell (D-) Rating for Arrowhead Pharmaceuticals (NASDAQ:ARWR) - MarketBeat

Oct 09, 2025

Oct 09, 2025

Arrowhead Pharmaceuticals (ARWR): Valuation Insights Following First-in-Class RNAi Therapy Trial Application - Sahm

Oct 09, 2025

Oct 09, 2025

Is Arrowhead Pharmaceuticals Inc. still worth holding after the dipM&A Rumor & Consistent Growth Stock Picks - newser.com

Oct 09, 2025

Oct 09, 2025

What technical models suggest about Arrowhead Pharmaceuticals Inc.’s comebackM&A Rumor & Low Volatility Stock Suggestions - newser.com

Oct 09, 2025

Oct 08, 2025

Arrowhead Pharmaceuticals (ARWR) Is Up 5.9% After Filing for First Dual-Gene RNAi Therapy Trial – Has the Long-Term Thesis Shifted? - Sahm

Oct 08, 2025

Oct 08, 2025

Arrowhead Pharma stock rating reiterated at Buy by H.C. Wainwright - Investing.com Canada

Oct 08, 2025

Oct 08, 2025

Arrowhead Pharmaceuticals (NASDAQ:ARWR) Given Buy Rating at HC Wainwright - MarketBeat

Oct 08, 2025

Oct 08, 2025

RBC Raises Price Target on Arrowhead Pharmaceuticals to $45 From $38, Keeps Outperform, Speculative Risk - MarketScreener

Oct 08, 2025

Oct 08, 2025

HC Wainwright & Co. Reiterates Arrowhead Pharmaceuticals (ARWR) Buy Recommendation - Nasdaq

Oct 08, 2025

Oct 08, 2025

Arrowhead Pharma (ARWR) Analyst Rating Update: HC Wainwright & C - GuruFocus

Oct 08, 2025

Oct 08, 2025

Arrowhead Pharmaceuticals Hits New 52-Week High of $39.42 - Markets Mojo

Oct 08, 2025

Oct 08, 2025

Arrowhead Pharmaceuticals Files CTA for Investigational ARO-DIMER-PA – the First Dual Functional RNAi Therapeutic for the Treatment of Mixed Hyperlipidemia - BioSpace

Oct 08, 2025

Oct 07, 2025

Arrowhead Pharmaceuticals Files CTA for Investigational ARO-DIMER-PA – the First Dual Functional RNA - PharmiWeb.com

Oct 07, 2025

Oct 07, 2025

Arrowhead Pharmaceuticals Hits New 52-Week High of $36.24 - Markets Mojo

Oct 07, 2025

Oct 07, 2025

RNAi: The Benefits Of Shooting The Messenger - Seeking Alpha

Oct 07, 2025

Oct 07, 2025

Arrowhead Pharmaceuticals And Wave Life Sciences: RNAi Is Getting Into Obesity (NASDAQ:WVE) - Seeking Alpha

Oct 07, 2025

Oct 07, 2025

Arrowhead Pharmaceuticals files CTA for investigational Aro-Dimer-PA - MarketScreener

Oct 07, 2025

Oct 07, 2025

Arrowhead files for approval of dual-target RNAi therapy for heart disease - Investing.com Nigeria

Oct 07, 2025

Oct 07, 2025

What Arrowhead Pharmaceuticals, Inc.'s (NASDAQ:ARWR) 29% Share Price Gain Is Not Telling You - simplywall.st

Oct 07, 2025

Oct 06, 2025

Arrowhead Pharmaceuticals (NASDAQ:ARWR) Reaches New 12-Month HighStill a Buy? - MarketBeat

Oct 06, 2025

Oct 06, 2025

Will Arrowhead Pharmaceuticals Inc. stock outperform Dow Jones indexJuly 2025 Price Swings & Verified Entry Point Signals - newser.com

Oct 06, 2025

Oct 06, 2025

Tools to monitor Arrowhead Pharmaceuticals Inc. recovery probabilityEarnings Miss & AI Driven Stock Price Forecasts - newser.com

Oct 06, 2025

Oct 03, 2025

Insider Sell: James Hamilton Sells 20,000 Shares of Arrowhead Ph - GuruFocus

Oct 03, 2025